J&J acquires cardio tech maker Abiomed for $16.6bn
J&J acquires cardiovascular medtech developer Abiomed for $16.6 billion
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
J&J acquires cardiovascular medtech developer Abiomed for $16.6 billion
Verge Genomics, backed by Eli Lilly and Merck & Co., announced it had dosed a human during clinical trials with a drug discovered.
The FDA has told healthcare providers to consider different MRI-guided breast biopsy procedure options due to a shortage of grid plates and coil.
HQ Team October 31, 2022: Best Agrolife, a BSE-listed company, announced that its subsidiary had received a patent from the Indian government to.
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.
2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based.
Glenmark Pharmaceuticals, an Indian biopharmaceutical company, has received an "import alert" from USFDA for its Baddi facility in Himachal Pradesh.
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.
Tuberculosis, the second deadliest infectious killer after Covid-19, claimed 1.6 million lives last year, including 187,000 HIV-positive patients, according to the WHO's 2022.
J &J gets approval from FDA for medicine to treat a type of blood cancer-Multiple Myeloma
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com